Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
3301
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $46.8K | ﹤0.01% |
53,200
-27,000
| -34% | -$55.7K |
|
3302
Zevia
ZVIA
$122M
| $46.8K | ﹤0.01% |
69,300
+39,000
| +129% | +$36.1K |
|
|
AKTX
3303
Akari Therapeutics
AKTX
$13.8M
| $46.1K | ﹤0.01% |
427
+58
| +16% | +$4.28K |
|
|
MKFG
3304
DELISTED
Markforged Holding Corporation
MKFG
| $46K | ﹤0.01% |
11,230
-19,585
| -64% | -$107K |
|
3305
SurgePays
SURG
$5.48M
| $45.3K | ﹤0.01% |
+14,200
| New | +$53.7K |
|
|
YQ
3306
17 Education & Technology Group
YQ
$18.7M
| $43.9K | ﹤0.01% |
20,530
-100
| -0.5% | -$254 |
|
3307
Rapid Micro Biosystems
RPID
$106M
| $43.6K | ﹤0.01% |
65,987
+8,600
| +15% | +$7.35K |
|
|
NCNA
3308
NuCana
NCNA
$5.49M
| $42.9K | ﹤0.01% |
84
| – | – |
|
|
NXXT
3309
NextNRG Inc
NXXT
$45.6M
| $42K | ﹤0.01% |
+8,732
| New | +$50.6K |
|
|
ASLN
3310
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $41.7K | ﹤0.01% |
17,358
+2,045
| +13% | +$7.24K |
|
|
BYU
3311
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $41.1K | ﹤0.01% |
35,000
-15,100
| -30% | -$18.1K |
|
3312
SHF Holdings
SHFS
$1.19M
| $40.5K | ﹤0.01% |
3,783
-3,787
| -50% | -$54.9K |
|
3313
Modular Medical
MODD
$12.9M
| $40.1K | ﹤0.01% |
+847
| New | +$41.4K |
|
|
KORE
3314
DELISTED
KORE Group Holdings
KORE
| $39.9K | ﹤0.01% |
18,840
+1,260
| +7% | +$4.4K |
|
3315
Indonesia Energy Corp
INDO
$44.3M
| $39.5K | ﹤0.01% |
14,378
-11,322
| -44% | -$39.1K |
|
|
ADIL
3316
Adial Pharmaceuticals
ADIL
$7.31M
| $39.5K | ﹤0.01% |
1,374
-670
| -33% | -$25.3K |
|
|
MOGU
3317
MOGU Inc
MOGU
$16.5M
| $39K | ﹤0.01% |
16,257
-300
| -2% | -$661 |
|
3318
SELLAS Life Sciences
SLS
$1.97B
| $38.6K | ﹤0.01% |
+32,446
| New | +$44.1K |
|
3319
Grove Collaborative
GROV
$46.2M
| $38.4K | ﹤0.01% |
+21,700
| New | +$34.7K |
|
|
DYNT
3320
DELISTED
Dynatronics Corp
DYNT
| $38.3K | ﹤0.01% |
144,418
+9,600
| +7% | +$4.12K |
|
3321
DSS Inc
DSS
$5.39M
| $38.1K | ﹤0.01% |
22,148
+1,000
| +5% | +$1.77K |
|
|
CCM
3322
Concord Medical Services
CCM
$19.2M
| $37.1K | ﹤0.01% |
3,910
-160
| -4% | -$1.07K |
|
3323
AmpliTech
AMPG
$118M
| $35.9K | ﹤0.01% |
34,200
-23,600
| -41% | -$41.9K |
|
|
BRNS
3324
Barinthus Biotherapeutics
BRNS
$22.8M
| $35.1K | ﹤0.01% |
25,100
-2,600
| -9% | -$5.87K |
|
|
FRSX
3325
Foresight Autonomous Holdings
FRSX
$3.9M
| $34.4K | ﹤0.01% |
1,707
+333
| +24% | +$7.76K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.